Here is what they say in the 2020 Investor presentation.Acrux is...

  1. 2,833 Posts.
    lightbulb Created with Sketch. 471
    Here is what they say in the 2020 Investor presentation.

    Acrux is able to develop and commercialise a generic drug
    for ~AUD$3-4m within ~4 years
    ▪ Once a licensing deal is executed and a product launched
    royalty/profit share revenue is expected to grow strongly

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.9¢
Change
-0.001(5.00%)
Mkt cap ! $7.747M
Open High Low Value Volume
2.0¢ 2.0¢ 1.9¢ $13.72K 687.1K

Buyers (Bids)

No. Vol. Price($)
6 618035 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 10000 1
View Market Depth
Last trade - 14.19pm 18/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.